{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T06:03:11Z","timestamp":1733896991576,"version":"3.30.1"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03584-y","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T14:25:21Z","timestamp":1733840721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eastern equine encephalitis: a critical dermatological clue in Massachusetts\u2019 health crisis"],"prefix":"10.1007","volume":"317","author":[{"given":"Kripa","family":"Ahuja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meghana","family":"Sunkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Lio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"3584_CR1","unstructured":"Archie A (2024) A Massachusetts town closes its parks to stop a mosquito-borne disease from spreading. NPR. https:\/\/www.npr.org\/2024\/08\/26\/nx-s1-5089737\/massachusetts-mosquito-disease-parks-fatal. August 26, Accessed August 26, 2024"},{"issue":"8","key":"3584_CR2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.3201\/eid2708.203730","volume":"27","author":"SC Brown","year":"2021","unstructured":"Brown SC, Cormier J, Tuan J et al (2021) Four human cases of Eastern Equine Encephalitis in Connecticut, USA, during a larger Regional Outbreak, 2019. Emerg Infect Dis 27(8):2042\u20132051. https:\/\/doi.org\/10.3201\/eid2708.203730","journal-title":"Emerg Infect Dis"},{"key":"3584_CR3","doi-asserted-by":"publisher","unstructured":"Division of Pulmonary, Care C, Medicine S, Ii S, Singh Kalra P (2021) S et al East Equine Encephalitis Consultant Published Online. https:\/\/doi.org\/10.25270\/con.2021.03.00007","DOI":"10.25270\/con.2021.03.00007"},{"issue":"4","key":"3584_CR4","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1097\/DER.0000000000000632","volume":"31","author":"SA Kullberg","year":"2020","unstructured":"Kullberg SA, Warshaw EM (2020) Summertime dermatitis: when the repellent is the Culprit, not the bugs! Dermatitis 31(4):e30\u2013e32. https:\/\/doi.org\/10.1097\/DER.0000000000000632","journal-title":"Dermatitis"},{"issue":"1","key":"3584_CR5","doi-asserted-by":"publisher","first-page":"8","DOI":"10.4269\/ajtmh.1995.52.8","volume":"52","author":"P Villari","year":"1995","unstructured":"Villari P, Spielman A, Komar N, McDowell M, Timperi RJ (1995) The Economic Burden imposed by a residual case of Eastern Encephalitis. Am J Trop Med Hyg 52(1):8\u201313. https:\/\/doi.org\/10.4269\/ajtmh.1995.52.8","journal-title":"Am J Trop Med Hyg"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03584-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03584-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T03:20:11Z","timestamp":1733887211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03584-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3584"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03584-y","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Lio reports research grants\/funding from AbbVie, AOBiome; is on the speaker\u2019s bureau for AbbVie, Arcutis, Eli Lilly, Galderma, Hyphens Pharma, Incyte, La Roche-Posay\/L\u2019Oreal, MyOR Diagnostics, ParentMD, Pfizer, Pierre-Fabre Dermatologie, Regeneron\/Sanofi Genzyme, Verrica; reports consulting\/advisory boards for Alphyn, AbbVie, Almirall, Amyris, Arcutis, ASLAN, Boston Skin Science, Bristol-Myers Squibb, Burt\u2019s Bees, Castle Biosciences, Codex Labs, Concerto Biosci, Dermavant, Eli Lilly, Galderma, Janssen, Johnson & Johnson, Kimberly-Clark, LEO Pharma, Lipidor, L\u2019Oreal, Merck, Micreos, MyOR Diagnostics, Regeneron\/Sanofi Genzyme, Skinfix, Theraplex, UCB, Unilever, Verrica Yobee Care; stock options with Codex, Concerto Biosciences and Yobee Care. In addition, Dr. Lio has a patent pending for a Theraplex product with royalties paid and is a Board member and Scientific Advisory Committee Member of the National Eczema Association.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"93"}}